文献速递血液透析通路

多中心研究:肱动脉移位在血液透析患者中的疗效

Multicentre Study on the Efficacy of Brachial Artery Transposition Among Haemodialysis Patients.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2021-03-11

这项多中心回顾性队列研究纳入2012年1月至2013年12月间接受肱动脉移位(BAT)的233例连续患者,评估其作为血液透析血管通路的效果。BAT在227例中成功,2年时移位肱动脉和通路回路的一期通畅率分别为88%和54%。BAT安全有效,移位肱动脉通畅率高,通路回路通畅率可接受,可考虑用于无法建立标准动静脉通路的患者。

要点

  • BAT技术成功率高,2年移位肱动脉一期通畅率88%。
  • 通路回路2年一期通畅率54%,回流途径失败需关注。
  • BAT可用于无法建立标准动静脉通路的透析患者。

核心结论

  • BAT安全有效,移位肱动脉通畅率高,通路回路通畅率可接受,可考虑用于无法获得标准动静脉通路的患者。

研究设计与样本

  • 多中心回顾性队列研究,纳入2012年1月至2013年12月间接受BAT的233例连续患者。

主要发现

  • BAT在227例中成功,透析期间血流量充足,首次成功穿刺中位时间为18天。
  • 并发症包括伤口愈合不良14例(其中皮肤坏死2例)、大动脉瘤6例(其中真菌性假性动脉瘤1例)、动脉血栓形成5例、手部缺血5例、淋巴漏4例、血肿/出血3例。
  • 因动脉血栓/狭窄、血肿/出血、皮肤坏死、大动脉瘤分别放弃移位肱动脉4、3、3、1例。
  • 回流途径失败48例,原因包括穿刺所致静脉损伤22例、动静脉内瘘血栓/狭窄14例、导管感染6例、导管闭塞6例。
  • 2年时移位肱动脉和通路回路的一期通畅率分别为88%和54%。

临床怎么用

  • 对于无法建立标准动静脉通路的血液透析患者,可考虑BAT作为血管通路选项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Brachial artery transposition (BAT) is not a well known method for obtaining vascular access (VA) for maintenance haemodialysis. This study evaluated the outcomes of BAT. METHODS: This multicentre retrospective cohort study included 233 consecutive patients who underwent BAT between January 2012 and December 2013. The indications were inadequate vessels for obtaining VA, severe heart failure, hand ischaemia, central vein stenosis/occlusion, or a history of catheter/graft infection. The transposed brachial artery was used only for arterial inflow and other routes were used for outflow. RESULTS: BAT was successful in 227 patients, and adequate blood flow was achieved during dialysis sessions. The first successful cannulation was after a median of 18 days. BAT was performed using superficial veins as the return route in 127 patients and arteriovenous fistula (AVF) creation in 63 patients to prevent maturation failure. In 41 patients with central venous catheterisation, the transposed brachial artery was used for arterial inflow. The complications of BAT were impaired wound healing in 14 patients, including skin necrosis in two; large aneurysms in six, including a mycotic pseudo-aneurysm in one; arterial thrombosis in five; hand ischaemia in five; lymphorrhoea in four; and haematoma/bleeding in three. The transposed brachial artery was abandoned in four, three, three, and one case of arterial thrombosis/stenosis, haematoma/bleeding, skin necrosis, and large aneurysm, respectively. Access to the return routes failed in 48 cases because of vein damage caused by cannulation in 22, AVF thrombosis/stenosis in 14, catheter infection in six, and catheter occlusion in six. At two years, the primary patency rates of the transposed brachial artery and access circuit were 88% and 54%, respectively. CONCLUSION: BAT is a safe and effective technique. The patency was high for the transposed brachial artery but adequate for the access circuit. BAT can be considered for patients with an unobtainable standard arteriovenous access.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Murakami M, Mori K, Hamanoue S, et al. Multicentre Study on the Efficacy of Brachial Artery Transposition Among Haemodialysis Patients. Eur J Vasc Endovasc Surg. 2021. PMID: 33716008. doi:10.1016/j.ejvs.2021.01.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。